The Lithuanian Lung Cancer Screening Model: Results of a Pilot Study
- PMID: 40563607
- PMCID: PMC12191307
- DOI: 10.3390/cancers17121956
The Lithuanian Lung Cancer Screening Model: Results of a Pilot Study
Abstract
Background/Objectives: In 2024, Lithuania developed a national lung cancer screening program (the Program), targeting individuals aged 50 to 70 years, regardless of their smoking history, with screenings conducted once every three years. The Program aims not only to actively detect lung nodules (lung cancer) but also to identify clinically significant concomitant findings. The pilot study aimed to evaluate the screening process's feasibility and organizational efficiency of the screening process, as well as its potential clinical effectiveness. Methods: Three family medicine centers were selected for participation. The Coordinating Center contacted individuals aged 50 to 70 sequentially and invited them to participate, regardless of smoking status. In total, 1014 individuals were prospectively enrolled and underwent low-dose chest computed tomography (LDCT) screening between 26 September 2024 and 14 February 2025. Results: Of the individuals invited, 76.1% agreed to participate. Lung-RADS v2022 category 4 nodules were identified in 1.4% of participants (n = 14), including six smokers and eight non-smokers. Additionally, one participant with a Lung-RADS category 2 nodule was diagnosed with squamous cell carcinoma originating from peripheral lung changes. Newly identified significant incidental findings were detected in 25.9% of participants: 5.1% had pulmonary or mediastinal findings (most commonly emphysema, interstitial lung changes, and bronchiectasis), 18.7% had cardiovascular findings (usually coronary artery calcification, aortic valve calcification, and aorta dilation), and 2.1% had other clinically relevant conditions (e.g., thyroid nodules, diaphragmatic changes). Following assessment by family physicians, 17.6% of all participants were referred to medical specialists, including pulmonologists, cardiologists, and others. Conclusions: This pilot study demonstrated that the Lithuanian lung cancer screening model is feasible, well-organized, and clinically valuable. The findings support the Program's readiness for broader implementation at the national level.
Keywords: lung cancer; pilot study; screening.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2. Cochrane Database Syst Rev. 2022. PMID: 35921047 Free PMC article.
-
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590. Health Technol Assess. 2021. PMID: 34668482
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Incentives for preventing smoking in children and adolescents.Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD008645. doi: 10.1002/14651858.CD008645.pub3. Cochrane Database Syst Rev. 2017. PMID: 28585288 Free PMC article.
References
-
- Ruano-Raviña A., Provencio M., Calvo de Juan V., Carcereny E., Moran T., Rodriguez-Abreu D., López-Castro R., Cuadrado Albite E., Guirado M., Gómez González L., et al. Lung Cancer Symptoms at Diagnosis: Results of a Nationwide Registry Study. ESMO Open. 2020;5:e001021. doi: 10.1136/esmoopen-2020-001021. - DOI - PMC - PubMed
-
- Kaushal A., Waller J., von Wagner C., Kummer S., Whitaker K., Puri A., Lyratzopoulos G., Renzi C. The Role of Chronic Conditions in Influencing Symptom Attribution and Anticipated Help-Seeking for Potential Lung Cancer Symptoms: A Vignette-Based Study. BJGP Open. 2020;4:bjgpopen20X101086. doi: 10.3399/bjgpopen20X101086. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources